9 results
Thumbnail

D2.217 - Structured Follow-Up Intervals Enhance Adherence to Sublingual Immunotherapy in Patients with Allergic Rhinitis: Real-World Evidence from a Stepwise Approach

Thumbnail

D2.218 - Effectiveness of the 300IR house dust mite sublingual tablet according to the patients’ sensitisation and allergy profile in the real-world, non-interventional VORAN study

Thumbnail

D2.226 - Evaluation of the Immunogenicity and Stability of an Aluminum-Adsorbed Allergen Immunotherapy Using Specific IgG Titration in a Murine Model

Thumbnail

D2.228 - Effectiveness and Safety of Subcutaneous Immunotherapy for Patients Allergic to Either Cat Dander or Dermatophagoides/Cat Dander: Real World Data

Thumbnail

D2.214 - TAPAS – non-inferiority of clinical effectiveness in children compared to adults: 3-year interim results of a long-term NIS

Thumbnail

D2.215 - A Prospective Long-Term Cohort Study with Seasonal Allergic Rhinitis (TAPAS) with MATAs in tree- and grass-allergic patients

Thumbnail

D2.220 - US Regional Difference in Allergen Immunotherapy Prescription Patterns: Focus on the South

Thumbnail

D2.221 - Exploring the effect of HDM SLIT-tablets on atopic dermatitis prescriptions in patients with pre-existing atopic dermatitis: Results from the Real-world Evidence of house dust Mite Immunotherapy Tablets (REMIT) study

Thumbnail

D2.227 - US Regional Difference in Allergen Immunotherapy Prescription Patterns: Focus on Puerto Rico